Last reviewed · How we verify

Spherule-derived coccidioidin — Competitive Intelligence Brief

Spherule-derived coccidioidin (Spherule-derived coccidioidin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Infectious Disease.

phase 3 Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Spherule-derived coccidioidin (Spherule-derived coccidioidin) — Nielsen BioSciences, Inc.. Spherule-derived coccidioidin is a vaccine derived from the spherules of the Coccidioides fungus, which stimulates an immune response against the fungus.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Spherule-derived coccidioidin TARGET Spherule-derived coccidioidin Nielsen BioSciences, Inc. phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Spherule-derived coccidioidin — Competitive Intelligence Brief. https://druglandscape.com/ci/spherule-derived-coccidioidin. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: